Skip to main content
. 2015 Jul 30;6(36):39225–39234. doi: 10.18632/oncotarget.4407

Figure 5. Knockdown of miR-454 inhibited invasion.

Figure 5

Knockdown of miR-454 inhibited the HepG2 cells invasion, whereas overexpression of miR-454 increased the HepG2 cells invasion. *p < 0.05, **p < 0.01, and ***p < 0.001.